# Using Nanotechnology Structured Water to Control Blood Glucose in Type 2 Diabetic Patients.

> **NCT04082351** · NA · COMPLETED · sponsor: **ALI KAMAL M. SAMI** · enrollment: 387 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Nanotechnology structured water ( Magnalife)
- **DIETARY_SUPPLEMENT:** ordinary water

## Key facts

- **NCT ID:** NCT04082351
- **Lead sponsor:** ALI KAMAL M. SAMI
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-03
- **Primary completion:** 2018-02-16
- **Final completion:** 2018-02-16
- **Target enrollment:** 387 (ACTUAL)
- **Last updated:** 2019-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04082351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04082351, "Using Nanotechnology Structured Water to Control Blood Glucose in Type 2 Diabetic Patients.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04082351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*